ArticleArXiv2025
Causal Machine Learning Analysis of Empirical Relative Biological Effectiveness (RBE) for Mandible Osteoradionecrosis in Head and Neck Cancer Radiotherapy.
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
11 authors.
Funding
Abstract
Background and Aims: Osteoradionecrosis (ORN) of the mandible is one of the most severe adverse events (AEs) for head and neck (H&N) cancer radiotherapy. Previous retrospective investigations on real-world data relied heavily on conventional statistical models that primarily elucidate correlation rather than establishing causal relationships. Through the novel causal machine learning method, we aim to obtain empirical relative biological effectiveness (RBE) for mandible ORN in head and neck (H&N) cancer patients treated with pencil-beam-scanning proton therapy (PBSPT). Methods: 1,266 H&N cancer patients were included: 335 patients treated by PBSPT and 931 patients treated by volumetric-modulated arc therapy (VMAT). We use 1:1 case-matching based on propensity scores to minimize the imbalance in clinical factors between patients treated with PBSPT and VMAT. The bias test of standardized mean differences (SMD) was applied on the case-matched patient cohorts. The causal machine learning method, causal forest (CF), was adopted to investigate the causal effects between dosimetric factors and the incidence of ORN. The dose volume constraints (DVCs) for VMAT and PBSPT were derived when the critical volumes of the derived DVCs lead to the largest average causal effect (ATE). RBE values were further empirically derived based on tolerance curves formed from the critical volumes of the derived DVCs. This was accomplished by comparing the equivalent constraint doses against the actual physical doses of PBSPT. To rigorously account for statistical variability in the RBE estimates, a bootstrap resampling method was applied to generate confidence intervals, thereby quantifying the uncertainty in the analysis. Results: 335 VMAT patients were case-matched to 335 PBSPT patients; however, standardized mean bias analysis revealed persistent covariate imbalances within each group, indicating residual confounding influence. Using CF modeling, we identified DVCs of mandible for ORN and found that PBSPT had lower critical volumes than those of VMAT, leading to empirical RBE exceeding 1.1 in the moderate dose range (1.61 at 40 Gy[RBE=1.1], 1.30 at 50 Gy, and 1.13 at 60 Gy). Conclusion: This study presents a novel application of causal machine learning to evaluate mandible ORN in radiotherapy, identifying DVCs linked to the strongest causal effects and deriving empirical RBEs from equivalent constraint dose analysis based on the tolerance curve. The results indicate that proton RBE may significantly exceed 1.1 in the moderate dose range (40-60 Gy[RBE=1.1]), underscoring the importance of incorporating the variable RBE into PBSPT treatment planning to mitigate the risk of ORN.
Identifiers
41040800PMC12486052What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.